Ohcanbohtosat - Kefei Wang
- Čájehuvvo 1 - 4 / 4
-
1
Physiologically Based Pharmacokinetic Models Are Effective Support for Pediatric Drug Development Dahkki Kefei Wang, Kun Jiang, Xiaoyi Wei, Yulan Li, Tiejie Wang, Yang Song
Almmustuhtton 2021Revisão -
2
A neurodevelopment-inspired self-evolving scaffold for nerve regeneration Dahkki Yizhu Shan, Lingling Xu, Xi Cui, Jin‐Xi Zhang, Han Ouyang, Xiangxiang Wang, Jing Huang, Jiangtao Xue, Kefei Wang, Dongchuan Wang, Engui Wang, Kailiang Ren, Dan Luo, Zhou Li
Almmustuhtton 2025Artigo -
3
Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma Dahkki Zhen Yu, Xiaojing Wei, Lanting Liu, Hao Sun, Teng Fang, Lu Wang, Ying Li, Weiwei Sui, Kefei Wang, Yi He, Yaozhong Zhao, Wenyang Huang, Gang An, Fancui Meng, Changjiang Huang, Tengteng Yu, Kenneth C. Anderson, Tao Cheng, Lugui Qiu, Mu Hao
Almmustuhtton 2022Artigo -
4
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma Dahkki Wei Liu, Wei Liu, Hesong Zou, L.P. Chen, Wenyang Huang, Rui Lv, Yan Xu, Huimin Liu, Yin Shi, Kefei Wang, Yi Wang, Wenjie Xiong, Shuhui Deng, Shuhua Yi, Weiwei Sui, Guangxin Peng, Yueshen Ma, Huijun Wang, Lulu Lv, Jianxiang Wang, Jun Wei, Lugui Qiu, Wenting Zheng, Dehui Zou
Almmustuhtton 2024Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Biology
Pharmacology
Anatomy
Apoptosis
Autologous stem-cell transplantation
Biochemistry
Biomedical engineering
Biotechnology
Bortezomib
Cancer
Cancer research
Carfilzomib
Cell biology
Cell cycle
Cell cycle checkpoint
Chemistry
Chimeric antigen receptor
Cytokine release syndrome
Drug
Drug development
Gastroenterology
Gene knockdown
Immunology
Immunotherapy
In vivo
Internal medicine
Lactacystin
Lymphoma
Multiple myeloma